Natural killer cell activity and sex hormone levels in mastopathy

Gynecological Endocrinology

Volumn 11, Issue 6, 1997, Pages 399-404

  Roszkowski, P I ^a   Hyc, A ^a   Stopinska Gluszak U ^b   Malejczyk, J ^a,c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Medical Center of Postgraduate Education   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Mastopathy; Natural killer cells; Sex hormones

Indexed keywords

CHROMIUM 51; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; PROLACTIN; SEX HORMONE;

ARTICLE; BREAST DISEASE; BREAST TUMOR; CANCER RISK; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031443809     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152567     Document Type: Article

References (23)

1. Hughes, L.E. (1991). Classification of benign breast disorders. Br. Med. Bull., 47, 251-7
2. Working Party for the Nordic Cancer Union (1990). Breast-cancer etiology. Int. J. Cancer, Suppl. 5, 22-39
3. Levi, F., Randimbison, L., Te, V.-C. and La Vecchia, C. (1994). Incidence of breast cancer in women with fibroadenoma. Int. J. Cancer, 57, 681-3
4. Sitruk-Ware, R., Sterkers, N. and Mauvais-Jarvis, P. (1979). Benign breast disease. I. Hormonal investigation. Obstet. Gynecol., 53, 457-60
5. Kumar, S., Mansel, R. E., Hughes, L. E., Woodhead, J. S., Edwards, C. A., Scanlon, M. P. and Newcombe, R. G. (1984). Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer, 53, 1311-15
6. Dogliotti, L., Fagginolo, R., Ferusso, A., Orlandi, F., Sandrucci, S., Tibo, A. and Angeli, A. (1985). Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic breast disease. Horm. Res., 21, 137-44
7. Peters, F., Pichardt, C. R. and Breckwoldt, M. (1985). Thyroid hormones in benign breast disease: normalization of exaggerated prolactin responsiveness to thyrotropin-releasing hormone. Cancer, 56, 1082-5
8. Dabre, P. D. (1990). Steroids and steroid receptors in growth control of cultured breast cancer cells. Int. J. Cancer, Suppl. 5, 5-21
9. Grossman, C. J. (1985). Interactions between the gonadal steroids and the immune system. Science, 227, 257-61
10. Daynes, R. A., Meikle, A. W. and Araneo, B. A. (1991). Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res. Immunol., 142, 40-5
11. Seaman, W. E., Blackman, M. A., Ginhart, T. D., Roubinian, J. R., Loeb, J. M. and Talal, N. (1978). β-Estradiol reduces natural killer cells in mice. J. Immunol., 121, 2193-8
12. Hanna, N. and Schneider, M. (1983). Enhancement of tumor metastasis and suppression of natural killer cell activity by β-estradiol treatment. J. Immunol., 130, 974-80
13. Storkus, W. J. and Dawson, J. R. (1991). Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules. Crit. Rev. Immunol., 10, 393-416
14. Reynolds, C. W. and Wiltrout, R. H. (eds) (1989). Functions of the Natural Immune System. (New York: Plenum Publ. Corp.)
15. Malejczyk, J., Majewski, S., Jablonska, S., Rogozinski, T. T. and Orth, G. (1989). Abrogated NK-cell lysis of human papillomavirus (HPV)-16-bearing keratinocytes in patients with precancerous and cancerous HPV-induced anogenital lesions. Int. J. Cancer, 43, 209-14
16. Pross, H. F., Sterns, E. and MacGillis, D. R. (1984). Natural killer cell activity in women at "high risk" for breast cancer with and without benign breast syndrome. Int. J. Cancer, 34, 303-8
17. Robinson, E., Rubin, D., Mekori, T., Segal, R. and Pollack, S. (1993). In two modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer. Cancer Immunol. Immunother., 37, 209-12
18. Garzetti, G. G., Ciavattini, A., Provinciali, M., Fabris, N., Cignitti, M. and Romanini, C. (1993). Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. Obstet. Gynecol., 81, 665-8
19. Roszkowski, P. I., Hyc, A. and Malejczyk, J. (1993). Natural killer cell activity in patients with ovarian tumors and uterine myomas. Eur. J. Gynaecol. Oncol., 14(Suppl), 114-17
20. Berry, J., Green, B. J. and Matheson, D. S. (1987). Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer. Eur. J. Cancer Clin. Oncol., 23, 517-20
21. Rothstein, S., Blomgren, H., Petrini, B., Wasserman, J. and von Stedingk, L. V. (1988). Influence of adjuvant tamoxifen on blood lymphocytes. Breast Cancer Res. Treat., 12, 75-9
22. Berry, J., Green, B. J. and Matheson, D. S. (1987). Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminogluthemide. Cancer Immunol. Immunother., 24, 72-5
23. Mannel, D. N., Falk, W. and Yron, I. (1990). Inhibition of murine cytotoxic T cell responses by progesterone. Immunol. Lett., 26, 89-94